News Coverage 09.19.19 Share on Twitter Share on Facebook Share on LinkedIn Celsius Therapeutics to Use Single-Cell Platform in Three New Immuno-Oncology Collaborations Related Announcement, Our Impact PICI-Founded Dispatch Bio Takes on Solid Tumors Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat